FDA Inspection 1256831 — BioLife Plasma Services LP

BioLife Plasma Services LP — FEI 3007959978

The FDA completed an inspection of BioLife Plasma Services LP on December 12, 2024 in Cedar Falls, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 12, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Cedar Falls, IA (United States)